Evidence map›Paper›PMID 36418088›Full record

Trial reportRMD open2022

Suprascapular nerve block for the treatment of adhesive capsulitis: a randomised double-blind placebo-controlled trial.

E Michael Shanahan, Tiffany K Gill, Elizabeth Briggs, Catherine L Hill, Gregory Bain, Timothy Morris

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in RMD open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06939530 narecruitingnot on this mapstarted 2025, after this paper: background citation

Comparision of Hydrodilatation Results at Different Volumes in Adhesive Capsulitis by Phases.

TypeinterventionalSponsorJavier Muñoz PazRan2025 to 2026Enrolled64ConditionsCapsulitis of Shoulder, HydrodilatationArmsHydrodilatation (20 ml), Hydrodilatation (40 ml)
NCT07097571 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Comparison of the Efficacy of Proximal and Distal Suprascapular Nerve Blocks Under Ultrasound Guidance in the Treatment of Patients Diagnosed With Adhesive Capsulitis

TypeinterventionalSponsorIstanbul University - CerrahpasaRan2025 to 2026Enrolled70ConditionsAdhesive Capsulitis of the Shoulder, Suprascapular Nerve BlockArmsGlenohumeral Joint Injection and Suprascapular Nerve Block
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

E Michael ShanahanRheumatology, Flinders Medical Centre, Adelaide, South Australia, Australia michael.shanahan@sa.gov.au.ORCID 0000-0001-8309-3289
Tiffany K GillThe University of Adelaide Faculty of Health and Medical Sciences, Adelaide, South Australia, Australia.ORCID 0000-0002-2822-2436
Elizabeth BriggsRheumatology, Flinders Medical Centre, Adelaide, South Australia, Australia.
Catherine L HillRheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
Gregory BainOrthopaedic Department, College of Medicine and Public Health, Bedford Park, South Australia, Australia.
Timothy MorrisPhysiotherapy Department, Flinders University College of Nursing and Health Sciences, Bedford Park, South Australia, Australia.
Flinders Medical Centre · AUFlinders University · AURoyal Adelaide Hospital · AUSouth Australian Health and Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAdhesive capsulitis is a common painful shoulder condition. Treatment for the condition remains unsatisfactory. Suprascapular nerve block (SSNB) shows promise as a treatment option for adhesive capsulitis but there are no randomised controlled trials that examine its effect on pain or duration of the condition. The objective of this study was to examine the efficacy of SSNB for the management of adhesive capsulitis.

methodsA randomised double-blind placebo-controlled trial of SSNB and standard therapy versus placebo and standard therapy was performed. In total, 54 patients were enrolled in the study. 27 patients received a glenohumeral joint (GHJ) injection and physiotherapy plus a 3-month SSNB, and 27 patients received a GHJ injection and physiotherapy plus a 3-month placebo injection. Patients were followed to resolution of their symptoms as measured by a combination of range of movement, pain scores, Shoulder Pain and Disability Index (SPADI) scores and perceived recovery scores. The primary outcome measure was time to resolution of symptoms.

resultsParticipants who received the SSNB reduced the duration of their symptoms of adhesive capsulitis by an average of 6 months (mean time to resolution 5.4 (95% CI 4.4 to 6.3) months vs 11.2 (95% CI 9.3 to 13) months) in the placebo group. They also had reduced pain scores, improved range of movement and lower SPADI scores compared with the placebo group across all time points.

conclusionSSNB reduced the duration of adhesive capsulitis and resulted in improved pain and disability experience for patients. TRIAL REGISTRATION NUMBER: Australian New Zealand Clinical Trials Registry (ANCTRN 12615001378516).

Indexed as

BursitisNerve BlockAustraliaHumansShoulder PainTreatment OutcomeAnalgesicsArthritisPhysical Therapy ModalitiesRehabilitation

Identifiers

PMID36418088
PMCPMC9685228
OpenAlexW4309821995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.